
Pharmacally
EMA
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in EMA
Drugs Safety AlertEMA Flags Deanxit Risks and Batch-Linked Immunoglobulin ReactionsThe EMA’s PRAC has initiated a safety review of Deanxit following reports of persistent neurological and psychiatric effects.Fact-Checked
Health TidingsSanofi’s Sarclisa SC Gets CHMP Nod with OBI OptionCHMP recommends approval of Sarclisa SC for multiple myeloma, supported by Phase 3 IRAKLIA data showing non-inferiority to IV formulation and improved patient experience…Fact-Checked
Health TidingsGSK’s Bepirovirsen Accepted by EMA for Review in Chronic Hepatitis BThe European Medicines Agency has accepted GSK plc’s filing for bepirovirsen in chronic hepatitis B, backed by Phase III B-Well trials demonstrating significantly higher functional cure rates versus…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.